摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-acetamido-2-deoxy-6-O-β-D-galactopyranosyl-D-galactose

中文名称
——
中文别名
——
英文名称
2-acetamido-2-deoxy-6-O-β-D-galactopyranosyl-D-galactose
英文别名
β-D-Gal-(1->6)-D-GalNAc;Gal-(β1→6)GalNAc;2-Acetamido-2-deoxy-6-O-beta-D-galactopyranosyl-D-galactopyranose;N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl]acetamide
2-acetamido-2-deoxy-6-O-β-D-galactopyranosyl-D-galactose化学式
CAS
——
化学式
C14H25NO11
mdl
——
分子量
383.353
InChiKey
ACKXCNXSQYSCQN-UUHITYSKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -4.7
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    198
  • 氢给体数:
    8
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    Lactose2-乙酰氨基-2-脱氧-D-吡喃半乳糖乙腈 为溶剂, 反应 15.0h, 以14 mg的产率得到2-acetamido-2-deoxy-6-O-β-D-galactopyranosyl-D-galactose
    参考文献:
    名称:
    使用来自圆形芽孢杆菌的β-D-半乳糖苷酶方便地合成β-D-半乳糖基二糖衍生物。
    摘要:
    β-D-Gal-(1-> 4)-β-D-GlcNAc-OC6H4NO2-p(对硝基苯基N-乙酰基-β-乳糖苷)和β-D-Gal-(1-> 6)- β-D-GlcNAc-OC6H4NO2-p(对硝基苯基N-乙酰基-β-异乳糖胺)是通过乳糖和对硝基苯基2-乙酰氨基-2-脱氧葡萄糖吡喃糖苷进行区域选择性合成的,其中β-D-半乳糖苷酶通过芽孢杆菌回旋菌并通过控制反应体系中有机溶剂的浓度。当有机溶剂的浓度较高时,仅形成(1→4)连接的二糖,而低浓度时生成(1→6)连接的异构体。酶进一步利用转糖基化作用导致β-D-Gal-(1→4)-D-GalNAc和β-D-Gal-(1→4)-β-D-的区域选择性形成GalNAc-OC6H4NO2-p。用酵素
    DOI:
    10.1016/0008-6215(83)85010-1
点击查看最新优质反应信息

文献信息

  • A convenient synthesis of β-d-galactosyl disaccharide derivatives using the β-d-galactosidase from Bacillus circulans
    作者:Taichi Usui、Shinobu Kubota、Hiroshi Ohi
    DOI:10.1016/0008-6215(83)85010-1
    日期:1993.6
    (p-nitrophenyl N-acetyl-beta-isolactosaminide) were regioselectively synthesized from lactose and p-nitrophenyl 2-acetamido-2-deoxy-glucopyranoside, employing transglycosylation by the beta-D-galactosidase from Bacillus circulans and by controlling the concentration of organic solvent in the reaction system. The (1-->4)-linked disaccharide was formed exclusively when the concentration of organic solvent was high
    β-D-Gal-(1-> 4)-β-D-GlcNAc-OC6H4NO2-p(对硝基苯基N-乙酰基-β-乳糖苷)和β-D-Gal-(1-> 6)- β-D-GlcNAc-OC6H4NO2-p(对硝基苯基N-乙酰基-β-异乳糖胺)是通过乳糖和对硝基苯基2-乙酰氨基-2-脱氧葡萄糖吡喃糖苷进行区域选择性合成的,其中β-D-半乳糖苷酶通过芽孢杆菌回旋菌并通过控制反应体系中有机溶剂的浓度。当有机溶剂的浓度较高时,仅形成(1→4)连接的二糖,而低浓度时生成(1→6)连接的异构体。酶进一步利用转糖基化作用导致β-D-Gal-(1→4)-D-GalNAc和β-D-Gal-(1→4)-β-D-的区域选择性形成GalNAc-OC6H4NO2-p。用酵素
  • Modulation of the P2Y2 receptor pathway
    申请人:P2-Science APS
    公开号:EP2036567A2
    公开(公告)日:2009-03-18
    The present invention relates to the field of regulating the activity of the purinergic receptors for the modulation of the vascular tone, particularly for the purpose of treatment of haemodynamic conditions by overriding of vasoconstriction activity, such as increases in sympathic vasoconstriction. Modulators, such as UTP analogues as described herein are preferably specific for P2Y2. Compounds capable of stimulating the P2Y2 receptor are suitable for the treatment or prevention wherein inhibition of vasoconstriction activity is desirable such as hypertension and hypertension relates disorders or diseases, whereas compound capable of counteracting the activity of the P2Y2 receptor are suitable for the treatment of or prevention wherein inhibition of vasodilatation is desirable.
    本发明涉及调节嘌呤能受体活性以调节血管张力的领域,特别是通过抑制血管收缩活性(如交感血管收缩增加)来治疗血流动力学疾病。调节剂,如本文所述的UTP 类似物,最好对 P2Y2 具有特异性。能够刺激 P2Y2 受体的化合物适用于治疗或预防需要抑制血管收缩活性的疾病,如高血压和高血压相关失调或疾病,而能够抵消 P2Y2 受体活性的化合物适用于治疗或预防需要抑制血管舒张的疾病。
  • Compounds that bind P2Y2 or P2Y1 receptors
    申请人:——
    公开号:US20040116339A1
    公开(公告)日:2004-06-17
    The invention provides peptides and compounds that can bind to P2Y 2 receptors that are useful for modulating the secretion of mucus within mucosal surfaces.
    本发明提供了能与 P2Y 2 受体,可用于调节粘膜表面的粘液分泌。
  • Highly efficient enzymatic synthesis of Galβ-(1→3)-GalNAc and Galβ-(1→3)-GlcNAc in ionic liquids
    作者:Carlos Bayón、Álvaro Cortés、José Berenguer、María J. Hernáiz
    DOI:10.1016/j.tet.2013.04.015
    日期:2013.6
    Ionic liquids (ILs) have emerged as an alternative to conventional organic media due to their high thermal and chemical stability, negligible vapour pressure, non-flammability and easy recycling. In this context, this work assesses the catalytic activity of a beta-galactosidase from Bacillus circulans ATCC 31382 (beta-Gal-3-NTag) in the synthesis of beta-(1 -> 3)-galactosides using different ILs. A noticeably increase in activity, retaining total regioselectivity was found in the synthetic behaviour of B. circulans beta-galactosidase in ILs as co-solvents and using a 1:5 molar ratio of donor (pNP-beta-Gal):acceptor (GlcNAc or GalNac). Yields up to 97% of beta-(1 -> 3) with different ILs were found. These reactions take place without noticeable hydrolytic activity and with total regioselectivity, representing a considerable improvement over the use of aqueous buffer or conventional organic solvents. Furthermore, reaction scaling up and IL recovery and recycling are feasible without losing catalytic action. Molecular modelling studies performed predict a three-dimensional interaction at the active centre between the acceptor and the water-IL mixture, which could explain the results obtained. (C) 2013 Elsevier Ltd. All rights reserved.
  • COMPOUNDS THAT BIND P2Y sb 2 /sb OR P2Y sb 1 /sb RECEPTORS
    申请人:KIMBERLY-CLARK WORLDWIDE, INC.
    公开号:EP1592436A2
    公开(公告)日:2005-11-09
查看更多